glp 1 and suicidal ideation Psychiatric Safety of GLP-1 Receptor Agonists Across Type 2 Diabetes Obesity: An Integrative Review GLP-1s have lower risk of

Vergaderruimtes De Directeurskamer Kalme sfeer, ingericht als moderne vergaderruimte

Muscle weakness or cramps

Ethics declarations Competing interests B.F., J.D.D., and B.Y

doi: 10.3389/fnins.2022.970925 Received 23 June 2022 Accepted 08 August 2022 Published 01 September 2022 Volume 16 - 2022 Edited by Sandeep Kumar Singh, Centre of Bio-Medical Research (CBMR), India Reviewed by Victor Bodart-Santos, Federal University of Rio de Janeiro, Brazil

Journal of Investigative Dermatology

However, from clinical studies alone, it is difficult to know how much of the benefit is due to direct effects in the joint and how much may be explained by weight loss or broader metabolic changes. That is why we wanted to address a basic mechanistic question first: whether GLP-1 is actually present in the joint environment